Ambulatory ECG monitoring specialists in Central London accepting AVIVA

The Cardiovascular PIT-STOP® clinic offers a comprehensive approach to assessing and reducing cardiovascular risk, beginning with primary intensive treatment for individuals who want to understand their likelihood of developing heart disease and take proactive steps to reduce it. It also provides the secondary treatment optimisation programme for people who have already experienced a heart attack, undergone stent implantation, or had bypass surgery, and who wish to minimise the chance of further events or progression of their condition.The PIT-STOP® Programme brings these two strands together to support long-term heart health through prevention and optimised care. By focusing on both those at high risk and those already living with cardiovascular disease, the programme aims to lower risk, prevent disease progression, and improve outcomes through personalised lifestyle guidance and carefully adjusted medical therapy.Healthy living remains the foundation of heart protection. A balanced diet low in saturated fat, salt, and processed foods, together with regular physical activity such as walking, swimming, or cycling, helps strengthen the heart and improve circulation. Maintaining a healthy weight can significantly reduce blood pressure, cholesterol levels, and the risk of diabetes, while avoiding smoking and keeping alcohol intake moderate can greatly enhance long-term cardiovascular health and overall wellbeing.In addition to lifestyle changes, several medications are proven to reduce the risk of heart attacks and strokes. Cholesterol-lowering treatments such as statins remain the cornerstone of therapy, with additional options including ezetimibe, PCSK9 inhibitors, and inclisiran for those who need further cholesterol reduction. Blood pressure–lowering and heart-protective medications, such as ACE inhibitors and related agents, help safeguard the cardiovascular system. Newer therapies used for diabetes and weight management, including GLP-1 receptor agonists like tirzepatide (Mounjaro) and semaglutide (Wegovy), as well as SGLT-2 inhibitors, can improve both metabolic health and cardiovascular outcomes. Emerging treatments, such as low-dose colchicine for selected patient groups, are also being explored for their potential protective benefits.The Cardiovascular PIT-STOP® clinic is designed to identify the people most likely to benefit from this integrated approach, including those with early-onset heart disease, recurrent cardiac events, peripheral vascular disease, previous bypass surgery, or diabetes. The service combines thorough cardiovascular risk assessment, including clinical evaluation and state-of-the-art imaging where appropriate, with personalised optimisation of medication, tailored support for diet, weight management, and physical activity, and access to the latest evidence-based therapies. Its purpose is simple: to help every patient live well, stay healthy, and reduce their chances of future heart problems through a carefully coordinated blend of lifestyle support and advanced medical care.

Located on London's South Bank, London Bridge Hospital’s SE1 campus hosts world-leading services spanning cardiac care and cancer treatment to the UK's largest private MS stem cell transplant programme, living donor liver and renal transplantation, a dedicated dialysis centre and a robotics urology theatre — all within contemporary inpatient facilities.What medical services does it specialise in? London Bridge Hospital is a multi-specialty acute private hospital with specialist units and teams covering an exceptional breadth of clinical disciplines across its campus: Cardiology (cardiac care, pioneering techniques for the full range of adult cardiac conditions) Cardiothoracic surgery Medical oncology (cancer care including haemato-oncology, gynaecological and urological cancers) Orthopaedic surgery (routine hip replacements to complex spinal reconstructions) Gastroenterology (digestive health, upper GI, colorectal surgery and HPB medicine) Urology (full range including robotic surgery and male reproductive conditions) Haematology (blood and marrow cancers, with an 18-chair chemotherapy unit) Neurology (including the largest private MS AHSCT stem cell transplant programme in the UK) Neurosurgery Nephrology (renal services, including living donor renal transplantation and dialysis) Otolaryngology — Head, Neck and Thyroid Centre (treating the largest number of head and neck patients in the country) Obstetrics and gynaecology (dedicated women's health services) What tests and treatments does it offer? Some of the medical tests and care services offered at London Bridge Hospital include: hip replacement, robotic urology surgery, chemotherapy (18-chair dedicated unit), endoscopy (JAG-accredited unit), liver transplantation (living donor), dialysis (including holiday dialysis in our four-bed centre), bone marrow transplant (MS AHSCT and haematological conditions) and anti-reflux surgery (including the Linx procedure for acid reflux disease) . What quality and safety standards does London Bridge Hospital meet? London Bridge Hospital holds an Outstanding CQC rating. Its campus includes a JAG-accredited endoscopy unit, an 18-chair chemotherapy suite, a robotics urology theatre and a four-bed dialysis centre. Consultant-led teams deliver integrated care across inpatient, day case and outpatient settings within a campus of seamlessly connected services. Where is London Bridge Hospital located? 27 Tooley Street, SE1. London Bridge station is 2 minutes away (Jubilee line, Southeastern and Thameslink). Near Borough Market. Urgent care walk-in available on site. What other HCA Healthcare UK centres are there in Central London? London Bridge Hospital works in close partnership with Leaders in Oncology Care (LOC) on Harley Street, which provides specialist systemic anti-cancer therapies — including chemotherapy, immunotherapy and targeted treatments — as part of the HCA Healthcare UK cancer care network.